Advertisement

External Irradiation of Poorly Differentiated Prostatic Carcinoma

  • F. Edsmyr
  • L. Andersson
  • P. Esposti
Part of the NATO Advanced Science Institutes Series book series (NSSA, volume 53)

Abstract

Esposti (1) reported on 469 cases of prostatic carcinoma of all grades who were given hormone treatment at the Karolinska Sjukhuset in Stockholm. The survival rate up to five years in this series is given in Fig. 1. However in the patients with grade 3 carcinoma and without evidence of dissemination the five-year survival was only 14%.

Keywords

Prostatic Carcinoma Aspiration Biopsy External Irradiation Palpable Tumor Estramustine Phosphate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    P.L. Esposti, Cytologic malignancy grading of prostatic carcinoma by transrectal aspiration biopsy, Scand. J. Urol. Nephrol. 5:199 (1971).PubMedCrossRefGoogle Scholar
  2. 2.
    S. Cantril, J. Vaeth, J. Green, and A. Schroeder, Radiation therapy for localised carcinoma of the prostate, Front Radiat. Ther. Oncol. 9:274 (1975).Google Scholar
  3. 3.
    M. Mantyla, Radiotherapy of carcinoma of the prostate, Strahlentherapie 154:542 (1978).PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1983

Authors and Affiliations

  • F. Edsmyr
    • 1
  • L. Andersson
    • 1
  • P. Esposti
    • 1
  1. 1.Karolinska SjukhusetStockholmSweden

Personalised recommendations